SCHEMBL8540980

SCHEMBL8540980

CN(C)Cc1cc(F)cc(CN2CCNCC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.44
HRH3 Q9Y5N1 2/20 0.41
CXCR4 P61073 10/20 0.41
MEN1 O00255 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
ADRA2C P18825 1/20 0.41
CCR2 P41597 1/20 0.41
CXCL12 P48061 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNH2 Q12809 1/20 0.40
NR1H2 P55055 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8525148 0.84 CYP2D6 (0.56) SIGMAR1MEN1KMT2ACYP3A4CYP2D6
SCHEMBL2926465 0.84 SIGMAR1 (0.55) SIGMAR1HRH3CXCR4MEN1CHRM2
SCHEMBL8521055 0.76 SIGMAR1 (0.47) SIGMAR1HRH3CXCR4MEN1CHRM2
SCHEMBL27997744 0.76 SIGMAR1 (0.47) SIGMAR1HRH3CXCR4MEN1CHRM2
SCHEMBL19262611 0.74 CYP3A4 (0.61) SIGMAR1HRH3CXCR4MEN1CHRM2
SCHEMBL8525941 0.73 SCN5A (0.43) SIGMAR1HRH3ALDH1A1
SCHEMBL24627237 0.73 SIGMAR1 (0.55) SIGMAR1HRH3CXCR4MEN1CHRM2
SCHEMBL14614188 0.72 ALDH1A1 (0.44) HRH3MEN1KMT2ATDP1ALDH1A1
SCHEMBL608181 0.71 ALDH1A1 (0.70) SIGMAR1CXCR4MEN1CHRM2KMT2A
SCHEMBL29566534 0.71 ALDH1A1 (0.70) SIGMAR1CXCR4MEN1CHRM2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012068450-A1 CYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION (US) 2012-05-24 WO disclosed